Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.46 |
| ▸ | PDIA6 | Q15084 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | NCF1 | P14598 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3920763 | 0.87 | CA2 (0.54) | HRH3SMN1; SMN2HTTNCF1CA2 | |
| SCHEMBL4786787 | 0.81 | MEN1 (0.53) | ALDH1A1KDM4ECA2 | |
| SCHEMBL21962847 | 0.80 | ALDH1A1 (0.57) | HRH3ALDH1A1PRMT6POLBSMN1; SMN2 | |
| SCHEMBL3919427 | 0.79 | KMT2A (0.50) | HRH3PDIA6ALDH1A1KDM4E | |
| SCHEMBL15132866 | 0.77 | HRH3 (0.59) | HRH3ALDH1A1PRMT6POLBSMN1; SMN2 | |
| SCHEMBL3869701 | 0.76 | HRH3 (0.53) | HRH3ALDH1A1PRMT6POLBSMN1; SMN2 | |
| SCHEMBL16945880 | 0.76 | ALDH1A1 (0.55) | HRH3ALDH1A1PRMT6POLBSMN1; SMN2 | |
| SCHEMBL3381044 | 0.76 | ESR1 (0.55) | HRH3ALDH1A1POLBSMN1; SMN2HTT | |
| SCHEMBL23430815 | 0.75 | HRH3 (0.63) | HRH3ALDH1A1POLBSMN1; SMN2HTT | |
| SCHEMBL1807162 | 0.75 | PDIA6 (0.53) | PDIA6ALDH1A1KDM4ECA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1797074-A4 | COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF IIII | ASTRAZENECA AB (SE) | 2009-04-01 | — | — | EP | claimed |
| EP-1797074-A1 | COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF IIII | AstraZeneca AB (SE) | 2007-06-20 | — | — | EP | claimed |
| WO-2006033627-A1 | COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF IIII | ASTRAZENECA AB (SE) | 2006-03-30 | — | — | WO | claimed |
| EP-1797074-A4 | COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF IIII | ASTRAZENECA AB (SE) | 2009-04-01 | — | — | EP | disclosed |
| EP-1797074-A1 | COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF IIII | AstraZeneca AB (SE) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006033627-A1 | COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF IIII | ASTRAZENECA AB (SE) | 2006-03-30 | — | — | WO | disclosed |